Why the study?
Data from randomized trials evaluating antithrombotic therapy in patients with atrial fibrillation and stable coronary artery disease were limited.
Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
May support NOAC monotherapy in AF with stable CAD; leaves open need for confirmatory trials.
A 2019 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: